RONCA, VINCENZO
 Distribuzione geografica
Continente #
AS - Asia 1.015
NA - Nord America 702
EU - Europa 173
SA - Sud America 153
AF - Africa 29
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.073
Nazione #
US - Stati Uniti d'America 665
SG - Singapore 591
CN - Cina 220
BR - Brasile 120
VN - Vietnam 91
IT - Italia 33
HK - Hong Kong 27
FR - Francia 20
DE - Germania 17
GB - Regno Unito 17
CA - Canada 16
AR - Argentina 13
IN - India 12
FI - Finlandia 11
CZ - Repubblica Ceca 10
EC - Ecuador 10
MX - Messico 10
PL - Polonia 10
BD - Bangladesh 9
SA - Arabia Saudita 9
IE - Irlanda 8
IQ - Iraq 7
JP - Giappone 7
NL - Olanda 7
SE - Svezia 7
ZA - Sudafrica 7
UA - Ucraina 6
EG - Egitto 5
ID - Indonesia 5
TR - Turchia 5
KZ - Kazakistan 4
MA - Marocco 4
MY - Malesia 4
NG - Nigeria 4
ES - Italia 3
GR - Grecia 3
PK - Pakistan 3
RU - Federazione Russa 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BO - Bolivia 2
CL - Cile 2
CO - Colombia 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EE - Estonia 2
JM - Giamaica 2
KE - Kenya 2
KG - Kirghizistan 2
LK - Sri Lanka 2
NO - Norvegia 2
NP - Nepal 2
PA - Panama 2
PH - Filippine 2
PT - Portogallo 2
RO - Romania 2
SV - El Salvador 2
TN - Tunisia 2
VE - Venezuela 2
AO - Angola 1
AT - Austria 1
AZ - Azerbaigian 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CR - Costa Rica 1
ET - Etiopia 1
GT - Guatemala 1
HU - Ungheria 1
IR - Iran 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
OM - Oman 1
PS - Palestinian Territory 1
PY - Paraguay 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SR - Suriname 1
TH - Thailandia 1
TL - Timor Orientale 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.073
Città #
Singapore 282
Ashburn 141
San Jose 128
Shanghai 105
The Dalles 87
Beijing 51
Ho Chi Minh City 32
Dallas 29
Hong Kong 25
Los Angeles 23
Boardman 22
Hanoi 18
New York 15
Helsinki 11
Montreal 10
São Paulo 10
Seattle 9
Warsaw 9
Brno 8
Dublin 8
Truccazzano 7
Amsterdam 6
Da Nang 6
Johannesburg 6
Riyadh 6
Tokyo 6
Brooklyn 5
Santa Clara 5
Stockholm 5
Assago 4
Baghdad 4
Benin City 4
Campinas 4
Chicago 4
Frankfurt am Main 4
Milan 4
Munich 4
Phoenix 4
Quito 4
Biên Hòa 3
Boston 3
Cairo 3
Council Bluffs 3
Denver 3
Dhaka 3
Dorridge 3
Giugliano in Campania 3
Haiphong 3
Hillsboro 3
Hải Dương 3
Lawrence 3
Naples 3
Orem 3
Porto Alegre 3
Princeton 3
Pune 3
Rio de Janeiro 3
Rome 3
San Francisco 3
Secaucus 3
São Bernardo do Campo 3
Ambato 2
Ankara 2
Athens 2
Atlanta 2
Bishkek 2
Brasília 2
Bucharest 2
Budrio 2
Buenos Aires 2
Campos dos Goytacazes 2
Can Tho 2
Charlotte 2
Chennai 2
Cipolletti 2
City of London 2
Colombo 2
Conselheiro Lafaiete 2
Curitiba 2
Fortaleza 2
Go Vap 2
Jeddah 2
Kyiv 2
Lisbon 2
London 2
Maceió 2
Manchester 2
Marseille 2
Mauá 2
Mexico City 2
Nairobi 2
Oslo 2
Panama City 2
Panipat 2
Paris 2
Poplar 2
Prague 2
Santo André 2
Tallinn 2
Thái Nguyên 2
Totale 1.259
Nome #
Recurrence of autoimmune liver diseases after liver transplantation: Review and expert opinion statement 80
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 80
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 73
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 65
Impact of Platelet Count on Perioperative Bleeding in Patients With Cirrhosis Undergoing Surgical Treatments of Liver Cancer 57
Gut-Liver Immune Traffic: Deciphering Immune-Pathogenesis to Underpin Translational Therapy 52
Direct oral anticoagulants and advanced liver disease: A systematic review and meta-analysis 51
Autoantibodies in patients with interleukin 12 receptor beta 1 deficiency 51
Ex situ Normothermic Split Liver Machine Perfusion: Protocol for Robust Comparative Controls in Liver Function Assessment Suitable for Evaluation of Novel Therapeutic Interventions in the Pre-clinical Setting 51
Ductular reaction, intermediate hepatocites and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis 50
Breakdown in hepatic tolerance and its relation to autoimmune liver diseases 50
Risk factors and outcomes associated with recurrent autoimmune hepatitis following liver transplantation 50
Clinical and prognostic implications of acute onset of Autoimmune Hepatitis: An Italian multicentre study 49
Incidence and Recurrence of Portal Vein Thrombosis in Cirrhotic Patients 49
Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Naive Patients With Primary Biliary Cholangitis: A Dual Cut-Off Approach 48
Pre-treatment risk stratification in primary biliary cholangitis: A predictive model to guide first-line combination therapy 47
Epidemiology and predictors of splanchnic thrombosis in liver transplant candidates: a single centre study 47
Immune system and cholangiocytes: A puzzling affair in primary biliary cholangitis 47
Assessment of advanced age candidates for liver transplantation warrants more caution 47
Toward precision medicine in primary biliary cholangitis 45
Expression of E-cadherin by CD8+ T cells promotes their invasion into biliary epithelial cells 45
Is ChatGPT a reliable tool in Autoimmune Hepatitis? 45
Prognostic models in primary biliary cholangitis 44
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score 44
Primary sclerosing cholangitis: Burden of disease and mortality using data from the national rare diseases registry in Italy 43
Conversion of CD4+T cells to functioning and epigenetically stable induced regulatory T cells in patients with primary biliary cholangitis 43
From pathogenesis to novel therapies in the treatment of primary biliary cholangitis 42
Ductular reaction, intermediate hepatocytes and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis 42
Donation after Circulatory Death Liver Transplantation in Paediatric Recipients 41
Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study 40
Predictors of serious adverse events and non‐response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 40
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 39
Novel therapeutics for primary biliary cholangitis: Toward a disease-stage-based approach 39
Incidence, prevalence and mortality of primary sclerosing cholangitis in Italy: A population-based study 37
The Immunological Basis of Liver Allograft Rejection 37
Type 2 Autoimmune Hepatitis and Nonadherence to Medication Correlate With Premature Birth and Risk of Postpartum Flare 37
New Therapeutic Targets in Autoimmune Cholangiopathies 36
An “unmodifiable” risk factor that has been modified 36
Precision medicine in primary biliary cholangitis 36
The invasion of the biliary epithelial cells by CD103+ CD69+ in-traepithelial cells CD8+ T lymphocyte and its role in the patho-genesis of primary biliary cholangitis 33
Use of immunosuppression in non-transplant hepatology 32
The Human Immune Response to Cadaveric and Living Donor Liver Allografts 31
Organ Restoration With Normothermic Machine Perfusion and Immune Reaction 30
Reply to: "A spotlight on natural killer cells in primary biliary cholangitis" 30
Moving Forward to New Trends in Liver Transplantation 29
Primary biliary cholangitis: a multifaceted pathogenesis with potential therapeutic targets 29
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 28
Quality of life in patients with primary biliary cholangitis: A cross-geographical comparison 28
Totale 2.125
Categoria #
all - tutte 12.558
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.558


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202213 0 0 0 0 0 0 0 0 5 0 8 0
2022/202322 7 1 4 0 2 0 0 0 2 4 2 0
2023/2024241 3 2 6 2 1 4 82 13 11 6 43 68
2024/2025594 17 5 8 11 6 92 36 62 84 138 74 61
2025/20261.255 224 73 52 113 88 78 406 91 79 51 0 0
Totale 2.125